Social Media Sidebar


Please sign up, comment on articles and bring your friends!

Current poll

PlanetTech is asking:

What do you think about our new web site?

Love it, indeed
Really good solution
Same as old one
The old one was better
This is a new option

Quote of the day

When seen through the lens of technology, few resources are truly scarce; they’re mainly inaccessible. 


Peter Diamandis

A promising HIV vaccine moves toward clinical trial

Posted in Science on 8th Jun, 2016 02:11 AM by AlexMuller

OHSU is using the same approach for other vaccines, starting with one against tuberculosis, which kills nearly 2 million people a year. Successful trials of the HIV vaccine will amount to a huge step forward in the fight against AIDS and give a green light to to attack other deadly infections, including malaria and hepatitis C.

"HIV is the poster child because it affects so many people, but there are many other conditions that are also extremely challenging to prevent or cure," said Dr. Marcel Curlin, an infectious disease specialist at OHSU who will run the HIV trials.
Getting OHSU's HIV vaccine to market could take just under a decade and cost tens of millions of dollars. Researchers need thousands of volunteers in Portland and across the country.
The vaccine is based on a weakened but "live" version of cytomegalovirus that's been engineered to look like HIV to the immune system. Cytomegalovirus is essentially the chassis that carries HIV-like genetic material into the body. HIV has been difficult to fight with a vaccine because the immune system must be trained to attack it. That takes time.
But cytomegalovirus has the unusual characteristic of keeping the immune system's killer T cells, the body's storm troopers, on high alert. By stitching HIV-like bits onto cytomegalovirus, the body is trained to attack HIV.
This approach, developed by OHSU's Dr. Louis Picker, is novel. Most vaccines rely on antibodies to kill pathogens before they take hold. This vaccine attacks HIV, the virus that causes AIDS, after cells become infected.
In animal trials, the vaccine has cured 50 to 60 percent of infected monkeys. Picker hasn't been able to figure out why he can't improve that rate. He suspects it has to do with the virulence of the virus used to infect the monkeys. Simian immunodeficiency virus is much more powerful than HIV.
"When you have such a hot pathogen, you can't defend the gates of Rome against every invader," Picker said. Picker hopes the vaccine will be more effective in humans. But before it can be tested for effectiveness, it must be proven safe.
While the vaccine contains genetic material similar to HIV to attract killer T cells, it can't infect volunteers with the virus. The human version of the vaccine resembles the one tested on monkeys, though OHSU still has a few technical details to work out. "It's one thing to produce it in our lab and it's another to manufacture it in a way to make it suitable for people," Picker said.
The manufacturing will be done by IDT Biologika, a German vaccine company with a U.S. base in Maryland, and could take perhaps six months. The first safety trial, due to start next year, will involve four groups, with the dose increasing in potency 10 times with each subsequent group.
The point of the safety trial is to monitor volunteers for adverse reactions and to check their immune response. If the vaccine produces severe side effects, the trial will stop.
If it doesn't produce any immune response, researchers will have to go back to the drawing board. But they don't expect that to happen, Curlin said.
The Food and Drug Administration has final authority over clinical trials. If the vaccine passes the first test, a second round of safety trials will be held with a bigger group of volunteers. The next step will test how well the virus works. To do that, the trials will take place in an area like South Africa where HIV infections are prevalent.
Other HIV vaccines are ahead of Picker's in this trial process. But he's not worried about that. It might take more than one vaccine to rid the world of HIV, he said.
If his approach succeeds, OHSU vaccines against tuberculosis, hepatitis C and the herpes virus could follow in the future.
"This prototype will affect all of those," Picker said. "That's why we want to (get) it right."

Tags: HIVAIDSvirushealthmedicineresearchvaccine

Read original article » Back to category


Author: Guest
Posted: 2016-06-08
Very promising! Successful trials of the HIV vaccine will amount to a huge step forward in the fight against AIDS
1 Replies
Author: Guest
Posted: 2016-06-08
Importantly, if this approach for HIV is successful, that has been difficult to fight with a vaccine because the immune system must be trained to attack it, this strategy can be used for other vaccines Reply


Recent headlines

  • Posted in Software on 2018-03-24 00:24:10
    Algorithm will allow for simulating an entire brain more
    Posted in Software on 2018-03-24 00:16:27
    DeepMind explores inner workings of artificial more
    Posted in Medicine on 2018-03-24 00:12:47
    Rise in cancers 'caused by weight' more
    Posted in Hardware on 2018-03-21 20:44:48
    Study: Apple Watch Cardiogram app bested EKG band more
    Posted in Medicine on 2018-03-21 20:42:10
    The wearable brain scanner you can move around more
Posted in Business on 2013-10-10 01:33
China is working towards a manned lunar mission in more
Posted in Business on 2013-10-20 07:17
Spacex says China is their main competitor for more
Posted in Software on 2013-10-20 06:43
Pirate Bay Browser Clocks 1,000,000 more
Posted in Medicine on 2013-10-10 02:10
Google reportedly investing hundreds of millions into more
Posted in Medicine on 2013-10-14 03:13
Endothelial Cells Can Repair and Regenerate Organs, more
Posted in Science on 01.01.2010
Spacex says China is their main competitor for more
Posted in Science on 01.01.2010
Staring at Your Phone Could Be Making You Short more
Posted in Science on 01.01.2010
Oculus Rift virtual reality headset coming to mobile, more
Posted in Science on 01.01.2010
China is working towards a manned lunar mission in more
Posted in Science on 01.01.2010
Delivering drugs via nanoparticles to target more

Recent Blog Posts

  • Posted by AlexMuller
    In five years quantum computing will be more
    Posted by AlexMuller
    Google partners with Johnson and Johnson to make lower more
    Posted by AlexMuller
    Electron holography microscope with spatial resolution down more
    Posted by AlexMuller
    Lower cost advanced Nuclear power could dominate future US more
    Posted by AlexMuller
    Why Hasn’t AI Mastered Language Translation? more

Login to your Account

Login to your PlanetTech Account here

Remember me

Create a New Account

You just need username and password

The following errors occured:
Verify password:
Remember me